-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Teslexivir
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1075798-37-6.gif)
| Category | Human papillomavirus (HPV) |
| CAS | 1075798-37-6 |
| Description | Teslexivir (BTA074) is a potent antiviral agent. Teslexivir is a potent and selective inhibitor of the interaction between two essential viral proteins, E1 and E2, an association that is a necessary step in the DNA replication and thus viral production for Human Papilloma Virus (HPV) 6 and 11. Teslexivir can be used for condyloma research. |
Product Information
| Synonyms | Teslexivir|1075798-37-6|UNII-SZ91E95340|SZ91E95340|4-[2-[2-(4-benzylphenyl)-2-(2-methyl-6-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-bromo-2-methoxybenzoic acid|Teslexivir [INN]|SCHEMBL15252044|HY-109045|CS-0031489|Benzeneacetic acid, 2-bromo-4-carboxy-5-methoxy-, 1-(2-(2-methyl-6-(1-piperidinyl)phenyl)-2-(4-(phenylmethyl)phenyl)hydrazide) |
| Molecular Weight | 642.58 |
| Molecular Formula | C35H36BrN3O4 |
| Canonical SMILES | CC1=C(C(=CC=C1)N2CCCCC2)N(C3=CC=C(C=C3)CC4=CC=CC=C4)NC(=O)CC5=CC(=C(C=C5Br)C(=O)O)OC |
| Purity | ≥98% (HPLC) |
| Density | 1.3±0.1 g/cm3 |
| Solubility | In Vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 886 |
| Exact Mass | 641.18892 |
| Index Of Refraction | 1.646 |
| Target | E1/E2/E3 Enzyme; HPV |
| XLogP3-AA | 8.1 |
